… Summary: Patients with peripheral arterial disease (PAD) are at very high risk of …
Furthermore, there is also support for positive effects of lipid-lowering on major adverse limb …

… Evidence suggests that statin therapy in patients with peripheral artery disease (PAD) is …
See the impact this article is making through the number of times it’s been read, and the …

… for patients taking statins with those taking nonstatin lipid-… ) and found that those patients
taking nonstatin lipid therapy did not … The magnitude of this effect is clinically evident with the …

… including smoking cessation, lipid lowering drugs, optimal glucose control, and antithrombotic
… to Buergers disease, nonatherosclerotic peripheral artery disease; however, the impact on …

… would be to consider the differential impact of lipid profiles in patients with CAD versus PAD.
… in the development of peripheral arterial disease and coronary artery disease: Edinburgh …

… Medical therapies targeting axes of risk, including lipid-modifying … Effects of Ticagrelor and
Clopidogrel with Patients with Peripheral Artery Disease (EUCLID) trial, 44% of patients with …

… substantial agreement in lipid-lowering medication use defined by Medicare pharmacy claims
and … Carotid artery stenosis in patients with peripheral arterial disease: the SMART study. …

… artery disease (LEAD) is a disabling disease which affects 40 million people in Europe
and 202 million people … (CAD), hyperlipidaemia, smoking, use of aspirin, and lipid-lowering …

… Peripheral artery disease (PAD), defined as atherosclerotic disease of the arteries supplying
the lower limbs, 1 affects >… disease in patients with PAD: measurements of total lipid, total …

… Treatment effect of alirocumab on peripheral artery disease and venous thromboembolism
… of VTE risk with a lipid-lowering intervention. However, in that trial, an effect of rosuvastatin to …